Diabetes mellitus is a complicated endocrine disorder affecting the major organs like liver, kidneys, heart and eyes and is rapidly affecting world population. According to WHO estimation, it might affect 300 million or more people in future. There is a need to discover new therapies for controlling this serious disease. Synthetic drugs have variable side effects whereas herbal medicine enjoys the benefit of very low side effects, therapeutically potent, low price and easy availability. People have diverted more attention on using these herbal remedies and researchers have diverted attention on developing safer drugs from plants to cure different ailments. There is also need to develop drugs for curing this serious ailment. Present review describes the recent exploration of different medicinal plants using streptozotocin induced animal models of rats and rabbits.
Introduction
Diabetes mellitus is a serious metabolic disorder of endocrine system effecting considerable population. Diabetes is a disorder indicating insufficient insulin production or increasing resistance to its performance [1-3]. Chemical agents are used generally to treat this upsetting disease but herbal treatments for diabetes have been used in patients with insulin dependent and non-insulin-dependent diabetes, diabetic retinopathy, diabetic peripheral neuropathy, etc. [1] . Diabetes is rapidly influencing the world population and especially type 2 diabetes with 90-95% occurrence resulting from impaired insulin production or consumption whereas World Health Organization estimated that it might affect the 300million or more population till 2025. Many oral hypoglycemic agents like biguanides, glinides and sulfonylureas are in use today to manage diabetes but they possess adverse side effects, so the research is focused mostly on the discovery of safer antidiabetic agents [4] . Herbal Approach Despite of advancements in the field of medicine, diabetes is still like a challenge causing mortality and morbidity in the world. Today, herbal products are in demand for the treatment of diabetes especially type two diabetes. There are various remedies to reduce complications caused by diabetes. Several investigations have been carried out to introduce herbal formulations; due to minor side effects and low cost [5, 6] . The quickly rising occurrence of diabetes mellitus is becoming a serious threat to human health in all over the world. During the last few years, bioactive drugs have been isolated from plants showing anti-diabetic potential. However, conventional medicine exhibited a good clinical practice and is showing a glowing future in the treatment of diabetes mellitus. Many studies have been carried out to prove the benefits of medicinal plants with hypoglycemic effects for managing the diabetes mellitus. The effects of these plants may delay the progress of diabetic complications and correct the metabolic abnormalities [7, 8] .
Herbal medicines have exhibited anti-diabetic activity through conventional usage. Researchers have proved that the anti-diabetic activity of medicinal plants is due to the presence of phenolic compounds, flavonoids, terpenoids, coumarins and other ingredients which show hypoglycemic activity like Accacia catechu, Vitex negundo, Murraya koenigii etc. [9] . Animal Models for Diabetes Mellitus Animal models provide opportunity to understand the pathophysiology and genetic and environmental factors leading to the development of disease and its complications, and thus providing insights for properly treating humans with new therapeutic agents with associated features. Most experiments are performed on rodents, even though other species with human-like biological characteristics are also used. Animal models can be obtained by either spontaneously or by using chemical agents or by surgical, genetic and dietary manipulations and represent many clinical features of disease. In recent years, various new genetically modified animal models including generalized knock-out, tissues pecific knockout and transgenic mice have been devised for studying diabetes [10, 11] . A large number of animal models have been devised for evaluating mechanism of actions of potential antidiabetic drugs and pathogenesis of Diabetes Mellitus [12] . Pharmacologically, streptozotocin and alloxan are widely used for the induction of diabetes in the experimental models. These drugs selectively destroy pancreatic beta cells while leaving the remaining pancreatic function intact and are used in small animals (mice, rabbits and cat). Investigator must ensure the minimization of pain and suffering in the experimental animal and this is legal and ethical responsibility of the researcher. Several animal models of diabetes are currently accessible. It is necessary to determine the animal model providing new insights into the respective problem. Species appropriateness must consider for performing experiment. Appropriate use of these animal models must be investigated to test the hypothesis and minimize the risk to animal [12] . The present review reveals the current discoveries on herbal therapeutics for diabetes using streptozotocin induced diabetic animal models. The following part presents the recent phytotherapeutic discoveries for diabetes.
Plants investigated for anti-diabetic activity

Ferula assafoetida
Asafoetida, an oleo-gum-resin obtained from the roots of Ferula assafoetida, is used for the treatment of different diseases like gastrointestinal disorders, epilepsy, influenza and asthma in traditional medicine system. The hypoglycemic activity of Asafoetida was evaluated in streptozotocin induced Male Wistar diabetic rats. The asafoetida extract showed significant hypoglycemic activity at dose of 50 mg/kg for 4 weeks, indicating the presence of the tannins and phenolic acids (ferulic acid) in the extract [13] .
Stevia rebaudiana
Aqueous extract of Stevia rebaudiana in combination of Momordicha charantia, Tamarindus indica, Gymnema sylvestre, Allium sativum and Murraya koenigii were evaluated for antidiabetic activity in the form of different polyherbal combinations. All these combinations were studied for their acute toxicity, Oral glucose tolerance test in normal rats, antidiabetic and anti-α amylase and α-glucosidase activity and liver function tests were checked. All combinations were safe and dose of 250 mg/kg was selected. Polyherbal combinations II showed significant antidiabetic activity indicating that tannins sterols and flavonoids may be present in this combination [14] . Adenanthera pavonina Linn. Antihyperglycaemic and lipid lowering effects of Adenanthera pavonina seed aqueous extract (APSAE) was evaluated in the streptozotocin induced diabetic rats. Treatment with APSAE showed considerable decrease (P<0.01) in plasma glucose, elevated levels of serum triglyceride and cholesterol levels were significantly decreased (P<0.01) by APSAE. APSAE treatment for 30 days showed significant decrease in serum LDL-cholesterol (P<0.01) and significant increase in serum HDL cholesterol level (P<0.01) and elevated the levels of HbA1c which was significantly increased (P<0.05) indicating that extract has the potential to treat diabetes condition and associated lipid disorders [15].
Panax ginseng
Historically, Panax ginseng has been used as herbal medicine. Antidiabetic efficiency of Panax ginseng berry extract was evaluated in streptozotocin induced diabetic mice. Hypoglycemic potential of extract in beta-cell deficient mice was evaluated and mechanisms involved were evaluated. Extract showed promising results stimulating increased insulin secretion indicating beta-cell regeneration and improved glycemic control [16] . Cassia javanica Kumavat et al., investigated the ornamental and therapeutically less acknowledged plant Cassia javanica for hypoglycemic ability in streptozotocin induced diabetic rats. First of all, drug was used to test acute oral toxicity. Formerly, phytochemistry of drug was checked by standard qualitative tests thus detecting antidiabetic compounds. Single and numerous doses of drug were given to rats under investigation. The conditions studied, were serum cholesterol, serum triglycerides, serum proteins, and blood glucose. These conditions were examined using acute and sub-acute treatment of test drug. The test drug and standard drug demonstrated considerable fluctuations in the abnormal levels of serum metabolites of diabetic rats [17] . Ocimum Gratissimum Aqueous leaf extract of Ocimum gratissimum (OG) was administered orally in streptozotocin induced Albino Wistar rats and parameters like water intake, food and weight changes were estimated. The extract was administered per oral to the diabetic-treated (DMT) groups at a dose of 1500 mg/k body weight daily for 28 days. 
Bauhinia purpurea
Methanolic extract of bark of Bauhinia purpurea was used to evaluate anti-diabetic activity in streptozotocin induced diabetic rats in comparison with normal rats. The experimental animals showed significant hypoglycemic activity of extract in a dose dependent manner. Antidiabetic effect might be due to the existence of flavonoids because flavonoids stimulate the insulin secretion, β-cell proliferation, inhibition of cyclooxygenases as proved from previous studies [38] . Cassia fistula Aqueous extract and gold nanopaticles were synthesized using Cassia fistula stem bark. Gold nanoparticles showed considerable changes in body weight and in serum glucose. Nanoparticles showed significant improvement in functions of kidney and liver and in the lipid profile in comparision with aqueous extract and reduction in serum biochemistry parameters. Results indicated that gold nanoparticles could be used as an efficient therapy for curing diabetic complication [39] .
Clausena anisata
The southern African medicinal native Clausena anisata (Wild) Hook is used for treating different diseases. The anti-diabetic effects of crude C. anisata leaf extracts were evaluated both in vivo and in vitro. The experiment proved that methanolic aqueous extracts showed efficient inhibition (>80%) of α-amylase than glucose-6-phosphatase inhibition in rabbit liver (60 and 58%). Acetone extract administration in rats failed to control postprandial hyperglycemia. Acetone extract also showed potent inhibition (> 80%) of Bacillus stearothermophillus α-glucosidase and human urinary α-amylase. However, the hypoglycemic effect of extract may not be due to the inhibitory effects on carbohydrate related enzymes [40] .
Melothria heterophylla
The ethanolic extracts of Melothria heterophylla aerial parts were administered to streptozotocininduced diabetic Swiss albino rats at the dose of 200 and 400 mg/kg, body weight. The plant extract and its active components showed significant (p < 0.01) control on blood glucose and serum enzymes including insulin. Rutin and gallic acid showed efficient (69.1 and 66.7%, respectively) hypoglycemic activity at the dose of 2 mg/kg and also enhanced the body weight and serum insulin in diabetic rats indicating the anti-diabetic activity of all experimental components [41].
Corn Silk
Corn silk polysaccharides were extracted using distilled water and precipitated using 80% solution of ethanol. The resulting extract was administered in streptozotocin-induced diabetic rats for the demonstration of anti-diabetic activities. The daily administration of the extract (100-500 mg/kg body weight) exhibited significant reduction in blood glucose and serum lipid levels. The polysaccharides also exhibited anti-depressant potential against dimethyl-biguanide in diabetic animals indicating a dose dependent behavior [42] . Rosemary Rosemary is an important dietary food used in everyday life in our food recipes to increase taste and flavor. Rosemary aqueous extract was administered in streptozotocin-induced diabetic rats for 4 weeks to study the anti-diabetic mechanisms of the extract. Rosemary extract perfusion resulted in the improvement of diabetes related parameter; decreased the sugar (20%), cholesterol (22%), triglyceride (24%), low density lipoprotein (27%) levels and increased high density lipoprotein (18%) level showing significance at (P < 0.01) and (P < 0.05), respectively [43]. Cassia auriculata L. The methanolic extract of Cassia auriculata L. flowers was administered in streptozotocin-induced diabetic rat models to evaluate antioxidant and antidiabetic potential. The inhibitory potential of extract on glucosidase and amylase was evaluated using acarbose as standard whereas biochemical parameters were studied using glibenclamid as reference drug. The extract resulted in the improvement of glucose level, glutathione, antioxidant enzyme potential, insulin level, DPPH radical scavenging ability and antilipid peroxide. Phytochemical analysis indicated the existence of quercetin, caffeine and catechins clueing the treatment of different diseases [44]. Elytraria acaulis Lind. Methanolic extract of Elytraria acaulis Lind. was administered at the dose of 200 and 400 mg/kg using glibenclamid (500 mcg/kg) as reference drug via the oral administration in diabetic rats. The high dose (400 mg/kg) of extract showed improved control on oral glucose tolerance test, bodyweight, and serum hemoglobin and liver glycogen levels. Histology of organs; liver, kidney and pancrease revealed the improved structures of islets of langerhans, hepatocytes, inhibition of glomerular hypertrophy and glomerulosclerosis indicating the antioxidant and anti-diabetic property of extract [45].
Emblica officinalis
Hydro-methanolic (20:80) extract of Emblica officinalis Gaertn. leaves, was administered in diabetic rats at different doses for 45 weeks to study the anti-diabetic effects using glibenclamid as reference. The extract showed improved blood glucose and serum insulin level at a noteworthy significance (P<0.05) and showed significant (P<0.05) decrease in biochemical parameters. The extract also improved the free radicals scavenging and antioxidant enzymes; superoxide dismutase, catalase, glutathione peroxidase and glutathione in dose dependent way [46].
Gmelina arborea
The ethanolic extract (150 mg/kg) of Gmelina arborea (Verbenaceae) was administered in male Wistar albino rats to study anti-diabetic effect comparing with glibenclamid (100μg/kg). Significant hypoglycemia resulting from dose administration in rats might be due to modulated β-cell function or glucose absorption in tissues or intestinal glucose uptake inhibition. The significant changes resulting from dose administration was comparable with standard drug glibenclamid [47]. Eugenia jambolana and Cinnamomum zeylenicum Different polyherbal formulations of Eugenia Jambolana-seed and Cinnamomum zeylenicum-bark were observed for in vitro antidiabetic activity. APKJ 004 polyherbal formulaion showed efficient antidiabetic activity to use for experimental study in wistar rats. The results indicated the increased absorption ability of APKJ 004 (112.3± 6.68 mg/dl) than glibenclamid (93.4±4.67mg/dl) and APKJ 004 decreased the glucose level (97.01± 6.23mg/dl) and increased the insulin level (06.75 ± 0.96 μU/ml--23.13±0.35μU/ml) as compared to glibenclamid. The phytochemical studies have detected the presence of glycosides, tannins, anthocyanins, flavonoids, alkaloids indicating its further use for experimental purposes [48].
Prosopis farcta
The southeastern Iranian plant (Prosopis farcta) extracts were investigated in male wistar rats for antidiabetic wound healing properties. 24 animals were divided into four groups. Three holes of 4 mm size on both dorsal sides of all rats were made to study wound healing effect of extracts on holes. The diabetic extract treated groups with root aquatic extract and fruit pod powder demonstrated the reduction in holes diameter efficiently (p< 0.05) and holes closed soon than in diabetic control group. Results revealed the skin regenerative effect of Prosopis farcta and its use in traditional medicine due to different therapeutic properties [49].
Geigeria alata
The methanolic extract of Sudanese medicinal plant; Geigeria alata, was administered at different doses in streptozotocin-induced diabetic rats orally for chronic treatment (14 days) or acute treatment (2 hours). The high dose (250 mg/kg) resulted in the reduction of blood glucose and enhanced the serum insulin with modulation of β-cells. In vitro analysis showed the improved anti-oxidant status and α-glucosidase inhibition, indicating the use of plant for controlling diabetes [50]. Guar gum Diet containing different percentages (0%, 5%, 10% and 20% w/w) of guar gum was administered to streptozotocin induced diabetic rats for evaluating antidiabatic potential at 0, 7.14 and 28 days interval comparing with glibenclamid (a reference drug). Guar gum improved the lipid index, polyuria, polyphagia, body weight, diet ingestion (P < 0.05), insulin activity, glucose levels resulting from diabetes induction. Experiment proved that the administration of guar gum in larger dose than glibenclamid is effective for controlling diabetic complications proving guar gum a reliable soluble fiber for body digestion [51].
Malva parviflora
The popular Mexican Malva parviflora was analyzed in the diabetic rats for antidiabetic potential. Different extracts (methanol, chloroform and hexane) were tested for lipid and cholestrol index, glucose and glycogen levels, insulin and antioxidant status, hepatic enzymes and protein glycation. Hexane extract reversed the abnormalities induced by streptozotocin in the rats indicating the interaction of plant components with targets that induce diabetes pathogenesis [52].
Phaleria macrocarpa
Phaleria macrocarpa fruit extracts were analyzed in normal and diabetic rats for hypoglycemic potential for a period of 12 days. Only methanol extract decreased blood glucose by 56.25 and 58.33% (P<0.05) and plasma insulin by 75 and 50% (P<0.05) compared with diabetic control and pre-treatment values. Results indicated that methanol extract contains terpenoids, tannins and flavonoids indicating that anti-diabetic potential of P. macrocarpa can be directed also by extra-pancreatic means [53] Curcumin Pharmacokineic and pharmacodynamic effects of glimepiride was checked using curcumin as adjuvant therapy and study was evaluated in diabetic mice. Pharmacokinetic parameters (AUC 0 to n , AUC total , C max, t 1/2 and MRT) were observed by administering glimepiride (1 mg/kg) on 8th day in one group, following cucumin (80 mg/kg) in another group for 7 days and glimepiride (1 mg/kg) following curcumin on 8 th day in same group whereas pharmacodynamic investigation was evaluated by using curcumin alone or as adjuvant with glimepiride at different concentrations in rats for 28 days. Blood samples and serum samples were investigated using High performance liquid chromatography and results indicated that curcumin prevents deviations in biochemical parameters and improves the consumption of glimepiride in the body. So, there is a need to optimize correct concentration of both ingredients for preparing better therapy [54]. Green Tea Extract Green tea extract (1.5%, w/v) was administered to the Diabetic Wistar rats. Experimental diabetes enhanced the ALP, AST, ALT, bilirubin and malondialdehyde index whereas reduction was observed in parameters; albumin, SOD, GSH, GSH-Px and CAT. Histopathological changes were consistent with the biochemical alterations. Extract administration improved the all hepatic tissue injury related parameters significantly (P < 0.05) and significantly reduced the blood glucose levels. Other reports also indicate the hypoglycemic properties but there is a need of much work related to antioxidant and hepatoprotective effects [55].
Salvia reuterana
Ethanolic extract of Salvia reuterana aerial parts was administered to diabetic wistar rats at different doses comparing with glibenclamid (600 mg/kg) for 14 days. Extract at the doses of 0.25 and 0.5 g/kg body weight improved the urea, creatinine, uric acid, insulin index, lipid disorders, serum glucose, alanine aminotransferase and aspartate aminotransferase providing evidence to control diabetes using aerial parts of Salvia reuterana [56]. Sesbania sesban (L) Merr. Aqueous extract of Sesbania sesban (L) Merr. leaves was administered to diabetic rats to investigate attenuating effects on sciatic nerves using pregabalin (10 mg/kg, p.o.) as standard for 12 weeks. The extract improved the total calcium levels, superoxide anion and tail flick latency and attenuated axonal degeneration in treated rats indicating neuroprotective effects. Motor co-ordination and motor activity observed at different time periods during study have no prominent changes as well as behavioral alterations remained as such during whole study period 
